Corient Private Wealth’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-55,000
Closed -$127K 2255
2023
Q2
$127K Buy
+55,000
New +$155K ﹤0.01% 1946

Other funds holding SLGC

Corient Private Wealth's SLGC Position: Q3 2023 in Review

Corient Private Wealth sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2023, closing a stake of 55,000 shares — an estimated $127K sold.

Corient Private Wealth first reported a position in SLGC in Q2 2023 and held it in 1 quarter. The position peaked at $127K in Q2 2023. 118 funds tracked by Wall St. Rank hold SLGC as of Q3 2023.

  • Corient Private Wealth reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Corient Private Wealth sold 55,000 SomaLogic, Inc. Class A Common Stock shares in Q3 2023, an estimated $127K.
  • Corient Private Wealth first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
  • Corient Private Wealth's SomaLogic, Inc. Class A Common Stock position peaked at $127K in Q2 2023.
  • 118 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2023.

Based on Corient Private Wealth's 13F filing for Q3 2023, filed 3 Nov 2023.